194 related articles for article (PubMed ID: 9021202)
1. Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice.
De Sarro G; Nava F; Calapai G; De Sarro A
Antimicrob Agents Chemother; 1997 Feb; 41(2):427-34. PubMed ID: 9021202
[TBL] [Abstract][Full Text] [Related]
2. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.
De Sarro G; Ammendola D; Nava F; De Sarro A
Brain Res; 1995 Feb; 671(1):131-40. PubMed ID: 7728525
[TBL] [Abstract][Full Text] [Related]
3. Quinolones potentiate cefazolin-induced seizures in DBA/2 mice.
De Sarro A; Zappalá M; Chimirri A; Grasso S; De Sarro GB
Antimicrob Agents Chemother; 1993 Jul; 37(7):1497-503. PubMed ID: 8395790
[TBL] [Abstract][Full Text] [Related]
4. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
5. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
[TBL] [Abstract][Full Text] [Related]
6. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
7. Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice.
De Sarro G; Chimirri A; Zappala M; Guisti P; Lipartiti M; De Sarro A
Gen Pharmacol; 1996 Oct; 27(7):1155-62. PubMed ID: 8981061
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
[TBL] [Abstract][Full Text] [Related]
9. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V
J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Pharmacol Biochem Behav; 1996 Oct; 55(2):281-7. PubMed ID: 8951966
[TBL] [Abstract][Full Text] [Related]
11. [Role of excitatory amino acids in neuropathology].
Wikinski SI; Acosta GB
Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.
Löscher W
Prog Neurobiol; 1998 Apr; 54(6):721-41. PubMed ID: 9560847
[TBL] [Abstract][Full Text] [Related]
13. Yohimbine-induced seizures involve NMDA and GABAergic transmission.
Dunn RW; Corbett R
Neuropharmacology; 1992 Apr; 31(4):389-95. PubMed ID: 1326092
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.
Chapman AG; Talebi A; Yip PK; Meldrum BS
Eur J Pharmacol; 2001 Jul; 424(2):107-13. PubMed ID: 11476756
[TBL] [Abstract][Full Text] [Related]
15. The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains.
Watanabe M; Miyai A; Danjo S; Nakamura Y; Itoh K
Exp Neurol; 2013 Sep; 247():645-52. PubMed ID: 23499834
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
[TBL] [Abstract][Full Text] [Related]
17. The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates.
Meldrum BS; Craggs MD; Dürmüller N; Smith SE; Chapman AG
Epilepsy Res Suppl; 1992; 9():307-11. PubMed ID: 1337444
[TBL] [Abstract][Full Text] [Related]
18. Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels.
Peña F; Tapia R
Neuroscience; 2000; 101(3):547-61. PubMed ID: 11113304
[TBL] [Abstract][Full Text] [Related]
19. Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters.
Micale N; Zappalà M; Grasso S; Puja G; De Sarro G; Ferreri G; De Sarro A; Toma L; De Micheli C
J Med Chem; 2002 Sep; 45(20):4433-42. PubMed ID: 12238923
[TBL] [Abstract][Full Text] [Related]
20. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
Pittaluga A; Bonfanti A; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
